company background image
4004 logo

Dallah Healthcare SASE:4004 Stock Report

Last Price

ر.س170.40

Market Cap

ر.س16.7b

7D

-1.6%

1Y

3.5%

Updated

15 Apr, 2024

Data

Company Financials +

Dallah Healthcare Company

SASE:4004 Stock Report

Market Cap: ر.س16.7b

4004 Stock Overview

Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia.

4004 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance5/6
Financial Health3/6
Dividends3/6

Dallah Healthcare Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dallah Healthcare
Historical stock prices
Current Share Priceر.س170.40
52 Week Highر.س194.00
52 Week Lowر.س131.40
Beta0.19
1 Month Change-6.48%
3 Month Change-0.12%
1 Year Change3.52%
3 Year Change192.28%
5 Year Change342.12%
Change since IPO397.96%

Recent News & Updates

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Apr 16
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Mar 18
What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Feb 25
Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Recent updates

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Apr 16
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Mar 18
What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Feb 25
Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward

Oct 30
Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward

Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return

Jul 26
Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return

Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)

Apr 17
Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)

Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Feb 06
Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends

Dec 05
Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Nov 01
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)

Aug 28
Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)

Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger

Aug 12
Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger

Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Jul 28
Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%

May 26
Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%

Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)

May 20
Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)

Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Apr 16
Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Feb 03
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Jan 10
Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Oct 19
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Jul 09
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically

Jun 16
Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically

Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher

May 02
Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher

What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?

Mar 17
What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?

Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?

Mar 02
Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?

Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year

Feb 15
Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year

Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?

Feb 01
Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?

Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 05
Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price

Dec 22
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price

Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?

Nov 20
Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?

Are Dividend Investors Getting More Than They Bargained For With Dallah Healthcare Company's (TADAWUL:4004) Dividend?

Jul 13
Are Dividend Investors Getting More Than They Bargained For With Dallah Healthcare Company's (TADAWUL:4004) Dividend?

Shareholder Returns

4004SA HealthcareSA Market
7D-1.6%0.3%0.09%
1Y3.5%22.4%1.8%

Return vs Industry: 4004 underperformed the SA Healthcare industry which returned 24.3% over the past year.

Return vs Market: 4004 underperformed the SA Market which returned 5.8% over the past year.

Price Volatility

Is 4004's price volatile compared to industry and market?
4004 volatility
4004 Average Weekly Movement4.0%
Healthcare Industry Average Movement4.6%
Market Average Movement4.8%
10% most volatile stocks in SA Market8.1%
10% least volatile stocks in SA Market2.6%

Stable Share Price: 4004 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4004's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1994n/aAhmad bin Babaeerwww.dallahhealth.com

Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, and medical polyclinics; and the provision of manpower and support services to hospitals and medical centers. It manufactures and distributes pharmaceutical, herbal and cosmetic products, and toiletries.

Dallah Healthcare Company Fundamentals Summary

How do Dallah Healthcare's earnings and revenue compare to its market cap?
4004 fundamental statistics
Market capر.س16.74b
Earnings (TTM)ر.س360.12m
Revenue (TTM)ر.س2.94b

46.2x

P/E Ratio

5.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4004 income statement (TTM)
Revenueر.س2.94b
Cost of Revenueر.س1.92b
Gross Profitر.س1.02b
Other Expensesر.س661.35m
Earningsر.س360.12m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)3.69
Gross Margin34.71%
Net Profit Margin12.24%
Debt/Equity Ratio54.6%

How did 4004 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

41%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.